CAVi is an app designed exclusively for Health Care Practitioners (HCPs) to discuss Cardiac Amyloidosis cases with International Practice Leaders, guaranteeing better health outcomes for these patients. The application complements the website in offering a secure environment with intuitive design, wherein de-identified patient information can be shared with multimedia attachments and a panel of experts will help the HCPs with their insights.
CAVi (Cardiac Amyloidosis Virtual Clinic), a speciality discussion board (the “Platform”), sponsored by Pfizer and developed by IQVIA contains facts, views, independent opinions, statements, and recommendations of verified Platform’s users and other third parties’ materials. You understand that the information and materials available through the Platform are for informational purposes only and are not intended to constitute professional advice, diagnosis or treatment, or to substitute your professional judgment. We do not represent or endorse the accuracy, completeness or reliability of any information or material displayed, uploaded or distributed through the Platform. You assume the full risk and responsibility for the use of the information and materials you obtain from or through the Platform.
CAVi (Cardiac Amyloidosis Virtual Clinic), a speciality discussion board (the “Platform”), sponsored by Pfizer and developed by IQVIA contains facts, views, independent opinions, statements, and recommendations of verified Platform’s users and other third parties’ materials. You understand that the information and materials available through the Platform are for informational purposes only and are not intended to constitute professional advice, diagnosis or treatment, or to substitute your professional judgment. We do not represent or endorse the accuracy, completeness or reliability of any information or material displayed, uploaded or distributed through the Platform. You assume the full risk and responsibility for the use of the information and materials you obtain from or through the Platform.
Show More
